Published in Tissue Antigens on June 25, 2009
A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosis. Nat Med (2011) 3.60
Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy? Nat Rev Microbiol (2010) 2.17
Cell-to-cell transfer of M. tuberculosis antigens optimizes CD4 T cell priming. Cell Host Microbe (2014) 1.61
Memory T cells in latent Mycobacterium tuberculosis infection are directed against three antigenic islands and largely contained in a CXCR3+CCR6+ Th1 subset. PLoS Pathog (2013) 1.54
Human and Murine Clonal CD8+ T Cell Expansions Arise during Tuberculosis Because of TCR Selection. PLoS Pathog (2015) 1.44
Antigen Export Reduces Antigen Presentation and Limits T Cell Control of M. tuberculosis. Cell Host Microbe (2016) 1.42
Suboptimal activation of antigen-specific CD4+ effector cells enables persistence of M. tuberculosis in vivo. PLoS Pathog (2011) 1.40
MicroRNA-155 promotes autophagy to eliminate intracellular mycobacteria by targeting Rheb. PLoS Pathog (2013) 1.29
Pathogenesis, immunology, and diagnosis of latent Mycobacterium tuberculosis infection. Clin Dev Immunol (2010) 1.29
The ESAT-6 protein of Mycobacterium tuberculosis interacts with beta-2-microglobulin (β2M) affecting antigen presentation function of macrophage. PLoS Pathog (2014) 1.02
Immunological consequences of intragenus conservation of Mycobacterium tuberculosis T-cell epitopes. Proc Natl Acad Sci U S A (2014) 1.01
M. tuberculosis T Cell Epitope Analysis Reveals Paucity of Antigenic Variation and Identifies Rare Variable TB Antigens. Cell Host Microbe (2015) 0.96
Beyond macrophages: the diversity of mononuclear cells in tuberculosis. Immunol Rev (2014) 0.93
Antigens for CD4 and CD8 T cells in tuberculosis. Cold Spring Harb Perspect Med (2014) 0.93
A recombinant attenuated Mycobacterium tuberculosis vaccine strain is safe in immunosuppressed simian immunodeficiency virus-infected infant macaques. Clin Vaccine Immunol (2012) 0.93
New approaches in the diagnosis and treatment of latent tuberculosis infection. Respir Res (2010) 0.92
Networked T cell death following macrophage infection by Mycobacterium tuberculosis. PLoS One (2012) 0.91
To achieve an earlier IFN-γ response is not sufficient to control Mycobacterium tuberculosis infection in mice. PLoS One (2014) 0.88
Mycobacterium tuberculosis NmtR harbors a nickel sensing site with parallels to Escherichia coli RcnR. Biochemistry (2011) 0.87
Role of PPE18 protein in intracellular survival and pathogenicity of Mycobacterium tuberculosis in mice. PLoS One (2012) 0.85
Disruption of immune regulation by microbial pathogens and resulting chronic inflammation. J Cell Physiol (2013) 0.85
The three Mycobacterium tuberculosis antigen 85 isoforms have unique substrates and activities determined by non-active site regions. J Biol Chem (2014) 0.84
ESAT-6-dependent cytosolic pattern recognition drives noncognate tuberculosis control in vivo. J Clin Invest (2016) 0.84
Recent Advances in Defining the Immunoproteome of Mycobacterium tuberculosis. Front Immunol (2013) 0.84
Improving Mycobacterium bovis bacillus Calmette-Guèrin as a vaccine delivery vector for viral antigens by incorporation of glycolipid activators of NKT cells. PLoS One (2014) 0.82
Mining large-scale response networks reveals 'topmost activities' in Mycobacterium tuberculosis infection. Sci Rep (2013) 0.82
Differential macrophage response to slow- and fast-growing pathogenic mycobacteria. Biomed Res Int (2014) 0.80
PPE26 induces TLR2-dependent activation of macrophages and drives Th1-type T-cell immunity by triggering the cross-talk of multiple pathways involved in the host response. Oncotarget (2015) 0.80
Epigenetics and Proteomics Join Transcriptomics in the Quest for Tuberculosis Biomarkers. MBio (2015) 0.79
Differential trafficking of TLR1 I602S underlies host protection against pathogenic mycobacteria. J Immunol (2012) 0.79
Exogenous control of the expression of Group I CD1 molecules competent for presentation of microbial nonpeptide antigens to human T lymphocytes. Clin Dev Immunol (2011) 0.78
A Quantitative Analysis of Complexity of Human Pathogen-Specific CD4 T Cell Responses in Healthy M. tuberculosis Infected South Africans. PLoS Pathog (2016) 0.78
Pre-exposure of Mycobacterium tuberculosis-infected macrophages to crystalline silica impairs control of bacterial growth by deregulating the balance between apoptosis and necrosis. PLoS One (2013) 0.78
ESAT-6 Targeting to DEC205+ Antigen Presenting Cells Induces Specific-T Cell Responses against ESAT-6 and Reduces Pulmonary Infection with Virulent Mycobacterium tuberculosis. PLoS One (2015) 0.78
Enhanced Direct Major Histocompatibility Complex Class I Self-Antigen Presentation Induced by Chlamydia Infection. Infect Immun (2015) 0.76
Current efforts and future prospects in the development of live mycobacteria as vaccines. Expert Rev Vaccines (2015) 0.76
Vaccines for TB: Lessons from the Past Translating into Future Potentials. J Immunol Res (2015) 0.76
Immune Responses to Bacillus Calmette-Guérin Vaccination: Why Do They Fail to Protect against Mycobacterium tuberculosis? Front Immunol (2017) 0.75
Mycobacterium tuberculosis Cell Wall Fragments Released upon Bacterial Contact with the Human Lung Mucosa Alter the Neutrophil Response to Infection. Front Immunol (2017) 0.75
Enhanced control of Mycobacterium tuberculosis extrapulmonary dissemination in mice by an arabinomannan-protein conjugate vaccine. PLoS Pathog (2017) 0.75
Differential Recognition of Mtb-specific Epitopes as a Function of Tuberculosis Disease History. Am J Respir Crit Care Med (2017) 0.75
Transcriptome Analysis of Mycobacteria-Specific CD4(+) T Cells Identified by Activation-Induced Expression of CD154. J Immunol (2017) 0.75
Autophagy fights disease through cellular self-digestion. Nature (2008) 33.83
The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med (2003) 24.99
Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet (2006) 21.60
Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA (1994) 14.96
Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell (2004) 12.71
Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. Science (1994) 10.04
Human IRGM induces autophagy to eliminate intracellular mycobacteria. Science (2006) 9.17
Characterization of the Mycobacterium tuberculosis phagosome and evidence that phagosomal maturation is inhibited. J Exp Med (1995) 6.62
Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes. Immunity (2006) 6.17
Cell-mediated immune responses in tuberculosis. Annu Rev Immunol (2009) 5.90
The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue. Proc Natl Acad Sci U S A (2003) 5.83
Toll-like receptor 4 is a sensor for autophagy associated with innate immunity. Immunity (2007) 5.36
Endogenous MHC class II processing of a viral nuclear antigen after autophagy. Science (2004) 5.10
M. tuberculosis and M. leprae translocate from the phagolysosome to the cytosol in myeloid cells. Cell (2007) 4.90
Viral evasion and subversion of pattern-recognition receptor signalling. Nat Rev Immunol (2008) 4.16
Phagosomes are competent organelles for antigen cross-presentation. Nature (2003) 3.97
Anti-immunology: evasion of the host immune system by bacterial and viral pathogens. Cell (2006) 3.83
Antimicrobial mechanisms of phagocytes and bacterial evasion strategies. Nat Rev Microbiol (2009) 3.83
Pathogenesis of tuberculosis: interaction of Mycobacterium tuberculosis with macrophages. Infect Immun (1993) 3.80
Induction of nonspecific acquired resistance and delayed-type hypersensitivity, but not specific acquired resistance in mice inoculated with killed mycobacterial vaccines. Infect Immun (1988) 3.79
Autophagy promotes MHC class II presentation of peptides from intracellular source proteins. Proc Natl Acad Sci U S A (2005) 3.75
Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo. J Immunol (2007) 3.73
Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs. J Exp Med (2007) 3.67
Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis. Nat Med (2003) 3.24
Depletion of CD4(+) T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon gamma and nitric oxide synthase 2. J Exp Med (2000) 3.20
Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guérin mutants that secrete listeriolysin. J Clin Invest (2005) 3.19
Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages. J Immunol (2000) 3.19
Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells. Nat Med (2009) 3.17
Protein kinase G from pathogenic mycobacteria promotes survival within macrophages. Science (2004) 3.16
Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model. Proc Natl Acad Sci U S A (2000) 3.07
Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis. J Immunol (2001) 3.06
Cross-presentation: underlying mechanisms and role in immune surveillance. Immunol Rev (2005) 2.98
The known unknowns of antigen processing and presentation. Nat Rev Immunol (2008) 2.85
Enhanced priming of adaptive immunity by a proapoptotic mutant of Mycobacterium tuberculosis. J Clin Invest (2007) 2.80
Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals. Am J Respir Crit Care Med (2009) 2.80
A coat protein on phagosomes involved in the intracellular survival of mycobacteria. Cell (1999) 2.77
Activation of human dendritic cells following infection with Mycobacterium tuberculosis. J Immunol (1997) 2.74
Secreted transcription factor controls Mycobacterium tuberculosis virulence. Nature (2008) 2.71
Mycobacterium tuberculosis blocks crosslinking of annexin-1 and apoptotic envelope formation on infected macrophages to maintain virulence. Nat Immunol (2008) 2.65
Apolipoprotein-mediated pathways of lipid antigen presentation. Nature (2005) 2.61
Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis. Immunity (2006) 2.61
Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein. J Immunol (2004) 2.56
Survival of mycobacteria in macrophages is mediated by coronin 1-dependent activation of calcineurin. Cell (2007) 2.51
Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells. Proc Natl Acad Sci U S A (2004) 2.49
Iron-cofactored superoxide dismutase inhibits host responses to Mycobacterium tuberculosis. Am J Respir Crit Care Med (2001) 2.46
Nonpeptide antigens, presentation mechanisms, and immunological memory of human Vgamma2Vdelta2 T cells: discriminating friend from foe through the recognition of prenyl pyrophosphate antigens. Immunol Rev (2007) 2.46
Mycobacterium tuberculosis and the environment within the phagosome. Immunol Rev (2007) 2.42
Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis. J Exp Med (1999) 2.42
Lamp-2a facilitates MHC class II presentation of cytoplasmic antigens. Immunity (2005) 2.40
Mycobacterium tuberculosis nuoG is a virulence gene that inhibits apoptosis of infected host cells. PLoS Pathog (2007) 2.36
Quantitative and dynamic assessment of the contribution of the ER to phagosome formation. Cell (2005) 2.35
Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis. J Immunol (1998) 2.33
Microbial isoprenoid biosynthesis and human gammadelta T cell activation. FEBS Lett (2003) 2.30
CD1 antigen presentation: how it works. Nat Rev Immunol (2007) 2.27
Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death. J Exp Med (2008) 2.17
Lipoprotein antigens of Mycobacterium tuberculosis. Res Microbiol (1991) 2.15
Inhibition of IFN-gamma-induced class II transactivator expression by a 19-kDa lipoprotein from Mycobacterium tuberculosis: a potential mechanism for immune evasion. J Immunol (2003) 2.13
ESAT-6-specific CD4 T cell responses to aerosol Mycobacterium tuberculosis infection are initiated in the mediastinal lymph nodes. Proc Natl Acad Sci U S A (2008) 2.10
Direct extracellular interaction between the early secreted antigen ESAT-6 of Mycobacterium tuberculosis and TLR2 inhibits TLR signaling in macrophages. Nat Immunol (2007) 2.08
Mycobacterium tuberculosis inhibits macrophage responses to IFN-gamma through myeloid differentiation factor 88-dependent and -independent mechanisms. J Immunol (2004) 2.08
Immune evasion by Mycobacterium tuberculosis: living with the enemy. Curr Opin Immunol (2003) 2.04
Delayed protection by ESAT-6-specific effector CD4+ T cells after airborne M. tuberculosis infection. J Exp Med (2008) 2.02
Mycobacterium tuberculosis LprG (Rv1411c): a novel TLR-2 ligand that inhibits human macrophage class II MHC antigen processing. J Immunol (2004) 1.95
Protein translocons: multifunctional mediators of protein translocation across membranes. Cell (2003) 1.86
Defined tuberculosis vaccine, Mtb72F/AS02A, evidence of protection in cynomolgus monkeys. Proc Natl Acad Sci U S A (2009) 1.86
Innate invariant NKT cells recognize Mycobacterium tuberculosis-infected macrophages, produce interferon-gamma, and kill intracellular bacteria. PLoS Pathog (2008) 1.81
Survival of Mycobacterium tuberculosis in host macrophages involves resistance to apoptosis dependent upon induction of antiapoptotic Bcl-2 family member Mcl-1. J Immunol (2003) 1.80
THP-1 cell apoptosis in response to Mycobacterial infection. Infect Immun (2003) 1.77
Major histocompatibility class I presentation of soluble antigen facilitated by Mycobacterium tuberculosis infection. Proc Natl Acad Sci U S A (1996) 1.76
Recent advances in antigen processing and presentation. Nat Immunol (2007) 1.75
Protective effect of a tuberculosis subunit vaccine based on a fusion of antigen 85B and ESAT-6 in the aerosol guinea pig model. Infect Immun (2004) 1.65
Identification and characterization of protective T cells in hsp65 DNA-vaccinated and Mycobacterium tuberculosis-infected mice. Infect Immun (1998) 1.64
Mycobacterium tuberculosis 19-kDa lipoprotein inhibits IFN-gamma-induced chromatin remodeling of MHC2TA by TLR2 and MAPK signaling. J Immunol (2006) 1.62
TLR2 and its co-receptors determine responses of macrophages and dendritic cells to lipoproteins of Mycobacterium tuberculosis. Cell Immunol (2009) 1.61
Mycobacterium tuberculosis infection causes different levels of apoptosis and necrosis in human macrophages and alveolar epithelial cells. Cell Microbiol (2003) 1.61
Rab14 is critical for maintenance of Mycobacterium tuberculosis phagosome maturation arrest. EMBO J (2006) 1.59
Cathepsin S controls the trafficking and maturation of MHC class II molecules in dendritic cells. J Cell Biol (1999) 1.58
Potent inhibition of macrophage responses to IFN-gamma by live virulent Mycobacterium tuberculosis is independent of mature mycobacterial lipoproteins but dependent on TLR2. J Immunol (2006) 1.57
An analysis of the epitope knowledge related to Mycobacteria. Immunome Res (2007) 1.53
CD4(+) and CD8(+) T cells kill intracellular Mycobacterium tuberculosis by a perforin and Fas/Fas ligand-independent mechanism. J Immunol (2001) 1.51
T cell responses to Listeria monocytogenes. Curr Opin Microbiol (2004) 1.47
Expression levels of Mycobacterium tuberculosis antigen-encoding genes versus production levels of antigen-specific T cells during stationary level lung infection in mice. Immunology (2006) 1.41
A role for dendritic cells in the dissemination of mycobacterial infection. Microbes Infect (2006) 1.38
Inhibition of major histocompatibility complex II expression and antigen processing in murine alveolar macrophages by Mycobacterium bovis BCG and the 19-kilodalton mycobacterial lipoprotein. Infect Immun (2004) 1.37
Mycobacterial manipulation of the host cell. FEMS Microbiol Rev (2005) 1.37
Mycobacterium tuberculosis inhibits maturation of human monocyte-derived dendritic cells in vitro. J Infect Dis (2003) 1.35
Down-regulation of CD1 on antigen-presenting cells by infection with Mycobacterium tuberculosis. J Immunol (1998) 1.35
Processing and presentation of a mycobacterial antigen 85B epitope by murine macrophages is dependent on the phagosomal acquisition of vacuolar proton ATPase and in situ activation of cathepsin D. J Immunol (2006) 1.34
Innate immune functions of human gammadelta T cells. Immunobiology (2007) 1.32
Activation of NKT cells protects mice from tuberculosis. Infect Immun (2002) 1.31
Mycobacterial lipoarabinomannan mediates physical interactions between TLR1 and TLR2 to induce signaling. J Endotoxin Res (2003) 1.31
Early T-cell responses in tuberculosis immunity. Immunol Rev (2008) 1.28
Mycolic acids constitute a scaffold for mycobacterial lipid antigens stimulating CD1-restricted T cells. Chem Biol (2009) 1.26
Secreted proteins from Mycobacterium tuberculosis gain access to the cytosolic MHC class-I antigen-processing pathway. J Immunol (2006) 1.24
Protective immunity to tuberculosis with Ag85B-ESAT-6 in a synthetic cationic adjuvant system IC31. Vaccine (2006) 1.20
Mycobacterium bovis bacillus Calmette-Guérin secreting active cathepsin S stimulates expression of mature MHC class II molecules and antigen presentation in human macrophages. J Immunol (2007) 1.16
Mycobacterium and Leishmania: stowaways in the endosomal network. Trends Cell Biol (1995) 1.12
Codominance of TLR2-dependent and TLR2-independent modulation of MHC class II in Mycobacterium tuberculosis infection in vivo. J Immunol (2007) 1.12
Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells. Nature (1994) 6.13
CD1-restricted T cell recognition of microbial lipoglycan antigens. Science (1995) 5.03
An antimicrobial activity of cytolytic T cells mediated by granulysin. Science (1998) 5.02
Murine CD1d-restricted T cell recognition of cellular lipids. Immunity (2000) 3.57
Differential effects of cytolytic T cell subsets on intracellular infection. Science (1997) 3.39
Evidence for extrathymic changes in the T cell receptor gamma/delta repertoire. J Exp Med (1990) 3.38
Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells. Science (1997) 3.23
CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J Exp Med (1998) 2.94
CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection. Nature (2000) 2.87
Self-recognition of CD1 by gamma/delta T cells: implications for innate immunity. J Exp Med (2000) 2.30
CD1c restricts responses of mycobacteria-specific T cells. Evidence for antigen presentation by a second member of the human CD1 family. J Immunol (1996) 2.13
The mannose receptor delivers lipoglycan antigens to endosomes for presentation to T cells by CD1b molecules. Immunity (1997) 2.07
CD1-restricted microbial lipid antigen-specific recognition found in the CD8+ alpha beta T cell pool. J Immunol (1999) 1.96
Response of murine and normal human skin to injection of allogeneic blood-derived psoriatic immunocytes: detection of T cells expressing receptors typically present on natural killer cells, including CD94, CD158, and CD161. Arch Dermatol (1999) 1.89
CD1b-mediated T cell recognition of a glycolipid antigen generated from mycobacterial lipid and host carbohydrate during infection. J Exp Med (2000) 1.67
Cytoplasmic tail-dependent localization of CD1b antigen-presenting molecules to MIICs. Science (1996) 1.66
Molecular recognition of lipid antigens by T cell receptors. J Exp Med (1999) 1.65
CD1-restricted T cells in host defense to infectious diseases. Curr Top Microbiol Immunol (2007) 1.62
Molecular interaction of CD1b with lipoglycan antigens. Immunity (1998) 1.60
The tyrosine-containing cytoplasmic tail of CD1b is essential for its efficient presentation of bacterial lipid antigens. Immunity (1998) 1.59
A pathway of costimulation that prevents anergy in CD28- T cells: B7-independent costimulation of CD1-restricted T cells. J Exp Med (1995) 1.54
Low expression level but potent antigen presenting function of CD1d on monocyte lineage cells. Eur J Immunol (2000) 1.43
The CD1 family of lipid antigen-presenting molecules. Immunol Today (1998) 1.42
Mycobacterium tuberculosis lipomannan induces apoptosis and interleukin-12 production in macrophages. Infect Immun (2004) 1.40
Analysis of human V alpha 24+ CD4+ NKT cells activated by alpha-glycosylceramide-pulsed monocyte-derived dendritic cells. J Immunol (2000) 1.38
Overexpression of CD1d by keratinocytes in psoriasis and CD1d-dependent IFN-gamma production by NK-T cells. J Immunol (2000) 1.37
Conservation of a CD1 multigene family in the guinea pig. J Immunol (1999) 1.34
CD1 expression in human atherosclerosis. A potential mechanism for T cell activation by foam cells. Am J Pathol (1999) 1.33
CD1 expression by dendritic cells in human leprosy lesions: correlation with effective host immunity. J Immunol (1999) 1.32
Distinct cytokine profiles of neonatal natural killer T cells after expansion with subsets of dendritic cells. J Exp Med (2001) 1.30
Diverse CD1d-restricted reactivity patterns of human T cells bearing "invariant" AV24BV11 TCR. Eur J Immunol (1998) 1.17
Characterization of a T cell line bearing natural killer receptors and capable of creating psoriasis in a SCID mouse model system. J Dermatol Sci (2000) 1.15
Evidence for human CD4+ T cells in the CD1-restricted repertoire: derivation of mycobacteria-reactive T cells from leprosy lesions. J Immunol (2000) 1.12
Selective diapedesis of Th1 cells induced by endothelial cell RANTES. J Immunol (1999) 1.11
Structure and function of the CD1 family of MHC-like cell surface proteins. Immunol Rev (1995) 1.11
Human double-negative T cells in systemic lupus erythematosus provide help for IgG and are restricted by CD1c. J Immunol (2000) 1.09
Human CD1b and CD1c isoforms survey different intracellular compartments for the presentation of microbial lipid antigens. J Exp Med (2000) 1.09
Intracellular trafficking pathway of newly synthesized CD1b molecules. EMBO J (2002) 1.08
Potent expansion of human natural killer T cells using alpha-galactosylceramide (KRN7000)-loaded monocyte-derived dendritic cells, cultured in the presence of IL-7 and IL-15. J Immunol Methods (2001) 1.06
CD1 proteins: targets of T cell recognition in innate and adaptive immunity. Rev Immunogenet (2000) 1.03
Mechanisms of autoimmune disease induction. The role of the immune response to microbial pathogens. Arthritis Rheum (1995) 1.02
Assembly and retention of CD1b heavy chains in the endoplasmic reticulum. J Immunol (1997) 1.01
The molecular basis of CD1-mediated presentation of lipid antigens. Immunol Rev (1999) 1.00
Expression of CD1d in the duodenum of patients with cow's milk hypersensitivity. Scand J Immunol (2000) 1.00
Alpha-glycosylceramides enhance the antitumor cytotoxicity of hepatic lymphocytes obtained from cancer patients by activating CD3-CD56+ NK cells in vitro. J Immunol (2000) 0.96
Antigen presentation by CD1 molecules and the generation of lipid-specific T cell immunity. Cell Mol Life Sci (2007) 0.96
Molecular recognition of human CD1b antigen complexes: evidence for a common pattern of interaction with alpha beta TCRs. J Immunol (2000) 0.92
Diversification of CD1 proteins: sampling the lipid content of different cellular compartments. Semin Immunol (2000) 0.91
Cytotoxic T lymphocytes in resistance to tuberculosis. Adv Exp Med Biol (1998) 0.90
Influence of Mycobacterium bovis bacillus Calmette Guérin on in vitro induction of CD1 molecules in human adherent mononuclear cells. Infect Immun (2001) 0.88
Antigen presentation by CD1 and MHC-encoded class I-like molecules. Curr Opin Immunol (1996) 0.88
Rifampin increases cytokine-induced expression of the CD1b molecule in human peripheral blood monocytes. Antimicrob Agents Chemother (1998) 0.86
Uptake and processing of glycosylated mycolates for presentation to CD1b-restricted T cells. Immunol Lett (1999) 0.85
CD1--a new paradigm for antigen presentation and T cell activation. Clin Immunol Immunopathol (1998) 0.84
An alpha-galactosylceramide C20:2 N-acyl variant enhances anti-inflammatory and regulatory T cell-independent responses that prevent type 1 diabetes. Clin Exp Immunol (2009) 0.83
The CD1 family and T cell recognition of lipid antigens. Tissue Antigens (2002) 0.83
Mechanisms of lipid antigen presentation by CD1. Crit Rev Immunol (1999) 0.82
Stimulation of a shorter duration in the state of anergy by an invariant natural killer T cell agonist enhances its efficiency of protection from type 1 diabetes. Clin Exp Immunol (2011) 0.81
Antigen-specific regulation of CD1 expression in humans. J Clin Immunol (2000) 0.81
CD1 trafficking: invariant chain gives a new twist to the tale. Immunity (2001) 0.80
Cytokine-induced expression of CD1b molecules by peripheral blood monocytes: influence of 3'-azido-3'-deoxythymidine. Pharmacol Res (1997) 0.79
Glycosyl-phosphatidylinositol reanchoring unmasks distinct antigen-presenting pathways for CD1b and CD1c. J Immunol (2000) 0.78
Cutting glycolipids down to size. Nat Immunol (2001) 0.77
Effect of rifampin on CD1b expression and double-negative T cell responses against mycobacteria-derived glycolipid antigen. Life Sci (1998) 0.77
Antigens and antigen-presenting molecules for gamma delta T cells. Curr Top Microbiol Immunol (1991) 0.77
T helper type 2-polarized invariant natural killer T cells reduce disease severity in acute intra-abdominal sepsis. Clin Exp Immunol (2014) 0.76
The CD1-restricted T-cell response to mycobacteria. Res Immunol (1997) 0.76